Infusion of glucose–insulin–potassium (GIK) before hospital admission in patients with signs and symptoms of acute coronary syndrome has been shown to reduce the incidence of cardiac arrest or in-hospital mortality. Whether out-of-hospital GIK in combination with strict glycemic control can prevent progression to MI requires further study.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Collaborative Activities of Noradrenaline and Natriuretic Peptide for Glucose Utilization in Patients with Acute Coronary Syndrome
Scientific Reports Open Access 24 May 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Goulston, A. West Indian cane sugar in treatment of certain forms of heart disease. BMJ 2, 693–695 (1912).
Sodi-Pallares, D. et al. Effects of an intravenous infusion of a potassium–glucose–insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am. J. Cardiol. 9, 166–181 (1962).
Apstein, C. S. & Taegtmeyer, H. Glucose–insulin–potassium in acute myocardial infarction: the time has come for a large, prospective trial. Circulation 96, 1074–1077 (1997).
Goyal, A., Nerenberg, K., Gerstein, H. C., Umpierrez, G. & Wilson, P. W. Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points. Diab. Vasc. Dis. Res. 5, 276–284 (2008).
Selker, H. P. et al. Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) trial: a double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services. Am. Heart J. 163, 315–322 (2012).
Selker, H. P. et al. Out-of-hospital administration of intravenous glucose–insulin–potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA 307, 1925–1933 (2012).
van der Horst, I. C. et al. Glucose and potassium derangements by glucose–insulin–potassium infusion in acute myocardial infarction. Neth. Heart J. 14, 89–94 (2006).
Timmer, J. R. et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation 124, 704–711 (2011).
Marfella, R. et al. Tight glycemic control may increase regenerative potential of myocardium during acute infarction. J. Clin. Endocrinol. Metab. 97, 933–942 (2012).
van der Horst, I. C. et al. The impact of glucose–insulin–potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]. BMC Med. 3, 9 (2005).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
van der Horst, I. Early metabolic modulation—a solution for MI?. Nat Rev Cardiol 9, 377–378 (2012). https://doi.org/10.1038/nrcardio.2012.75
Published:
Issue date:
DOI: https://doi.org/10.1038/nrcardio.2012.75
